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The pathophysiology and mechanism of Breath-Holding Spells (BHS) 
remain controversial, and the relationship between BHS and anemia 
has not been clarified, although iron supplementation appears to be 
effective in many patients. We aimed to assess the probable relation 
of iron level with initiation of these spells in children.
Materials & Methods
Overall, 42 children with a diagnosis of BHS, aged between 6 months 
to 2 yr were enrolled during Mar 2015 to Dec 2016 at Rasht 17th 
Shahrivar Hospital, Rasht, northern Iran. Ferrous sulfate solution 
prescribed 6 mg/kg/d, 3 times daily, for all of cases, regardless of their 
iron levels, and the response to the treatment was evaluated.
Results
Twenty-five patients were boys (59.52%). The mean age for all 
patients was 11.71±4.63 months. Positive family history detected 
in 33.33%; iron deficiency anemia in 21.42%, depletion of iron 
stores in 52.38%, and normal iron status in 26.19% of cases. Simple 
spells showed significantly higher mean of Hb in comparison with 
severe spells (P=0.008); also increased number of spells per month 
significantly decreased the mean of Hb (P=0.007). Mean frequency 
of spells was 40.14±47.08 before and 11.14±31.10 after iron therapy, 
per month (P<0.0001). Overall, 32 patients (76.19%) had complete 
control of spells, 7 patients (16.66%) partial, 2 cases (4.76%) weak, 
and 1 child (2.38%) no response after iron therapy.
Conclusion
Iron deficiency anemia may have an important role in BHS, and 
treatment of anemia may decrease number of the spells.
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Introduction
“Possibly the earliest report of Breath-Holding 
Spells (BHS) was published in 1737 by Nicolas 
Culpepper” (1-4).
Episodes of BHS are usually accrued in children 
without any underlying diseases, during expiration. 
These attacks are scary for parents because they are 
similar to some life-threatening diseases. About 
60% of affected children have the cyanotic form 
of BHS, about 20% of affected children have the 
pallid form, and additional 20% have both types of 
breath holding spells. The family history is 20%-
30% positive in these patients. Pathophysiology 
and mechanism of BHS remain controversial (5-
15).
Iron deficiency anemia is frequently seen in infants 
(16,17). Iron is very important for neurological 
functioning, including neurotransmitters, myelin 
formation, and brain energy metabolism (18-
23). As iron is a very important factor for proper 
neurological functions, it may have an important 
role in initiation of BHS. Iron supplements appear 
to be effective in many BHS patients (24-27).
We aimed to assess the probable relation of iron 
level with initiation of these spells in children.
Materials & Methods
All 6 months to 2 yr children with diagnosis of 
BHS, without history of previous convulsion, 
developmental delay, neurological deficit, chronic 
illness, primary cardiac disease, current treatment 
with anticonvulsant medications, or not reliable for 
drug consumption were enrolled, conducted during 
Mar 2015 to Dec 2016 at Rasht 17th Shahrivar 
Hospital, Rasht, Iran. Demographic information, as 
well as data about developmental milestones, type 
of BHS, age at onset, frequency and duration and 
severity of attacks before and after iron therapy, 
associated phenomenon, usual triggering factors, 
history of previous iron therapy, positive family 
history, and overall response to treatment were 
collected for all cases.
Patients attacks were classified into 3 types: 
cyanotic, pallid, and mixed, based on skin color 
change during attacks. These spells were classified 
as simple and severe (with loss of consciousness 
and jerking movements) episodes.
Routine hematological tests were performed for 
all patients on the early morning. Red blood cell 
count, hemoglobin (Hb), and hematocrit (Hct), as 
well as mean corpuscular volume (MCV), mean 
corpuscular hemoglobin (MCH), mean corpuscular 
hemoglobin concentration (MCHC), total iron 
binding capacity (TIBC), plasma ferritin (PF), and 
serum iron concentration, were collected for each 
patient.
The patients were divided into 3 groups, based on 
hematological status including normal serum iron, 
depletion of iron stores (decreased serum iron and 
serum ferritin, increased TIBC, but normal Hb, 
MCV, and MCH), and iron deficiency anemia. 
We defined iron deficiency anemia as follows: Hb 
less than 10.5 g% (for 6 months to 2 yr old cases), 
Hct<33%, MCV less than 70 fl, MCH less than 23 
pg, MCHC less than 30 g/%, RBC<3.7, and serum 
iron concentration less than 40 µg/dl (for patients 
younger than 12 months old) and greater than 50 
µg/dl (for cases older than 12 months old), PF less 
than 7 µg/I, and TIBC greater than 430 mcg/dl.
We prescribed oral ferrous sulfate solution 6 mg/
kg/d, 3 times daily, for all of cases, regardless of their 
iron levels. We evaluated the clinical condition of 
the patient with 3 months follow up; their response 
to treatment defined as follows: “complete”, the 
attacks disappeared completely; “partial”, >50% 
reduction in the number of attacks; “weak”, 10%-
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50% reduction in the attacks; and “no response”, 
<10% reduction in the attacks.
Written informed consent was obtained for all 
parents. This study was approved by the Ethics 
Committee at Guilan University of Medical 
Sciences (GUMS).
Variables are shown by mean ± SD and compared by 
means of the paired t test, ANOVA, and McNemar 
test. Statistical significance was calculated as 
P<0.05.
Results
There were 42 children with diagnosis of BHS, 
aged between 6 months to 2 yr (mean age was 
11.71±4.63 months), 25 patients were boys 
(59.52%) and 17 were girls (40.48%), with male 
predominance in the all age groups (boy/girl ratio 
was 1.47:1) (Figure 1). 
Cyanotic spells were observed in 35 patients 
[(83.33%), 22 boys and 13 girls). Pallid spells in 
4 patients [(9.52%), 1 boy and 3 girls] and mixed 
spells in 3 cases [(7.14%), 2 boys and 1 girl]. 
Positive family history of BHS was seen in 14 
children (33.33%). While iron deficiency anemia 
was observed in 9 children (21.42%), 22 children 
(52.38%) had depletion of iron stores of the body, 
and 11 cases (26.19%) had normal iron status.
Fifteen patients (35.71%) had history of previous 
iron supplement therapy [one patient (6.66%) with 
iron deficiency anemia, 5 cases (33.33%) with 
depletion of iron stores of the body, and 9 patients 
(60%) with normal iron status].
Patient’s iron level was shown in Table 1. Simple 
spells were shown significantly higher mean of Hb 
in comparison with severe spells (P= 0.008); also 
increased number of spells per month significantly 
decreased the mean of Hb (P= 0.007).
Results of iron therapy in children with BHS are 
detailed in Table 2. Overall, 32 patients (76.19%) 
had complete control of spells, 7 patients (16.66%) 
partial, 2 cases (4.76%) weak, and 1 child (2.38%) 


















Figure 1. Distribution of patients between age groups
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Table 1. Patient’s Blood indices 













11.45±0.62 2 (16.66%) 9 (75%) 1 (8.33%)
15≥spells/month
(No.=17)
11.55±0.65 2 (11.76%) 6 (35.29%) 9 (52.94%)
Simple spells
(No.=29)




10.67±0.48 11 (84.5%) 2 (15.5%) 0 (0%)
Table 2. Characteristics of spells before and after iron therapy
Characteristic of spells
Before iron therapy After iron therapy
P-value
No. % No. %
Frequency
/month
>30 13 30.95 4 9.52
<0.0001
15-30 12 28.57 1 2.38
<15 17 40.47 37 88.09
mean 40.14 ± 47.08 11.14 ± 31.10
Severity 
Simple 29 69.04 41 97.61
<0.001Severe 13 30.95 1 2.38
Table 3. Summery of studies
Citation Study group Study type Result




Case series 96% of the study group had iron deficiency anemia. 82% 
showed
Response within 2 wk. After three weeks 100% of cases 
had shown an improvement.
Colina and abelson 
(1995) (15)
2 cases Case report Improvement after treatment of anemia





With ferrous sulfate 
or placebo
Complete response in 51.5% of treated versus 0% in 
non-treatment group. Partial response in 36.4% of treated 
group versus 5.9% in non-treatment group. 




Case-control Complete response in 50.7% and
Partial response in 33.3% and no response in 16% after 
therapy. 
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Before & after 
study
Anemia was present in 76% of cases. Improvement in 
88.9% after iron therapy.
Mul et al (2005) 
(46)
1 case Case report Improvement after treatment of anemia
Discussion
The present study designed to assess the probable 
relation of iron level with BHS in children, and 
findings revealed that iron deficiency plays an 
important role on initiation of these spells. Results 
of this study had some similarities with other 
studies in this field, as well as some differences. 
Linder in a prospective study on 697 patients 
reported mild BHS in 4.7% and severe BHS in 
1.7% of cases (5), consistent with data presented in 
the current report.
Positive family history was reported in 20%-30% 
of BHS patients; genetic factors may play an 
important role in this disease, with a low-penetrance 
autosomal dominant factor (28). Although about 
50% positive family history reported in some 
studies (24); but some other studies failed to 
demonstrate positive family history in the BHS 
patients (29). We revealed 33.33% positive family 
history in our patients, confirmed the results of the 
first studies.
Multiple spells per week reported in majority of 
patients; about one-third of cases will experience 
more than one spell per day (30), similar to our 
cases.
Cyanotic spells were seen in 54% of cases, pallid 
in 22%, both types in 12%, and not classifiable in 
7% of patients (31, 32). This is different from our 
cases, as the cyanotic: pallid: mixed ratio in our 
patients has emerged as 35:4:3.
Iron deficiency anemia is common worldwide, 
especially in children living in developing countries 
(21, 33). Several causative factors (psychological 
problems and different physiologic mechanisms, 
such as cardiac inhibition through vagus nerve with 
painful stimuli, or central inhibition of respiratory 
movements, role of decreased sensitivity of 
CNS to hypoxia and hypercapnia, abnormalities 
in lung reflexes and movements) for BHS are 
suggested, but its exact etiology is unclear (6, 7). 
Iron deficiency anemia is frequently seen in BHS 
patients, and iron therapy may have a role in its 
treatment (Table 3). Holowach et al first described 
the association between BHS and anemia (26).
The causative mechanism of iron deficiency in 
BHS is not fully understood, probably it plays a 
role through neurotransmitters, enzymes, and 
catecholamine metabolism (31). Some other studies 
suggested the role of reduced oxygen availability 
to CNS, because of adverse effects of anemia on 
oxygen uptake in the lungs (24), and the probable 
role of erythropoietin, nitric oxide and interleukin 
1 (25). Our study revealed the important role of 
iron in the treatment of BHS because the mean 
frequency of spells was significantly higher before 
iron therapy (P<0.0001); and severity of spells 
significantly decreased after therapy (P<0.001). 
We observed complete control of BHS in 76.19% 
of our cases, after iron therapy. In our cases, simple 
spells are shown significantly higher mean of Hb 
in comparison with severe cases; Mean Hb level 
was significantly lower when number of spells per 
month increased.
160
Effectiveness of Iron Therapy on Breath Holding Spells in the Children
Iran J Child Neurol. Autumn 2019 Vol.13 No. 4
In conclusion, iron deficiency anemia might have 
an important role in BHS, and treatment of anemia 
may decrease number of the spells.
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